You should work towards supporting your body and metabolism
Gasoyan added that, in this large observational study of patients who discontinued semaglutide or tirzepatide, reinitiation of the original medication or receipt of alternative obesity treatment was common, which may explain why they regained less weight than patients in randomized trials. Additionally, previous research suggests that GLP-1 drug discontinuation often occurs for practical reasons rather than lack of effectiveness
What makes it interesting is that glucagon receptor: in the Phase 3 TRIUMPH program, the top dose reached weight reductions in the region of 30 percent, territory that used to belong to surgery rather than injections
MDR-001 On December 26, 2022, MindRank announced US FDA clearance of IND application for MDR-001
New safety signal: dysesthesia (abnormal skin sensations) in up to 21% of participants on the highest dose
It includes consults, meds, supplies, and shipping, but no coaching or lifestyle support